construction release_alert

The Scholars Team is working with OIT to resolve some issues with the Scholars search index

cancel

Development of a cabozantinib (Cabometyx)symptom management application for use in patients with renal cancer"; XL184-IST50

Clinical Trial Grant

Duke Scholars

Principal Investigator Sundhar Ramalingam Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Exelixis, Inc

Start Date

November 7, 2018

End Date

November 6, 2023

Administered By

Duke Cancer Institute

Awarded By

Exelixis, Inc

Start Date

November 7, 2018

End Date

November 6, 2023